NOVT

+ Watchlist + Portfolio

Novanta Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $145.94
52-Week Range: $98.27 – $176.38
Market Cap: $5.50B
P/E (TTM): 92.69
EPS (TTM): 1.57
Dividend Yield: —

Advanced Metrics

Price/Book: 3.40
PEG Ratio: —
Return on Equity: 5.11%
Return on Assets: 4.09%
Gross Margin: 44.54%
Operating Margin: 11.50%
Profit Margin: 6.00%
Current Ratio: 4.57
Debt/Equity: 0.18
Total Debt: $285.60M
Free Cash Flow: $118.38M
Revenue Growth: 10.30%
Earnings Growth: 150.00%
Enterprise Value: $5.07B

NOVT Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$860.90M	$881.66M	$949.25M	$980.60M
Cost of Revenue	$482.43M	$481.76M	$527.70M	$545.32M
Gross Profit	$378.47M	$399.90M	$421.55M	$435.28M
Research & Development	$85.77M	$91.68M	$95.52M	$95.48M
Selling, General & Admin	$158.90M	$164.46M	$175.94M	$195.66M
Operating Expenses	$271.01M	$276.59M	$297.25M	$318.62M
Operating Income	$107.46M	$123.31M	$124.29M	$116.66M
EBITDA	$160.62M	$169.92M	$179.86M	$178.60M
Pretax Income	$87.16M	$83.75M	$79.07M	$69.64M
Income Tax	$13.11M	$10.87M	$14.98M	$15.81M
Net Income	$74.05M	$72.88M	$64.09M	$53.83M
Diluted EPS	2.06	2.02	1.77	1.47
Diluted Shares	35.91M	36.03M	36.12M	36.70M

NOVT Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$100.11M	$105.05M	$113.99M	$380.87M
Receivables	$139.21M	$147.51M	$159.10M	$194.26M
Inventory	$168.00M	$149.37M	$144.61M	$188.28M
Current Assets	$420.52M	$415.30M	$433.65M	$782.60M
Total Assets	$1.24B	$1.23B	$1.39B	$1.81B
Current Liabilities	$164.52M	$139.18M	$167.79M	$212.37M
Long-Term Debt	$430.66M	$349.40M	$411.95M	$212.54M
Total Debt	$489.38M	$404.56M	$470.24M	$301.91M
Total Liabilities	$663.63M	$552.60M	$642.81M	$492.82M
Retained Earnings	$130.58M	$203.46M	$267.55M	$321.38M
Shareholders' Equity	$577.59M	$673.46M	$745.70M	$1.31B
Working Capital	$256.00M	$276.12M	$265.86M	$570.23M
Net Debt	$335.36M	$249.32M	$302.65M	—

NOVT Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$90.78M	$120.08M	$158.51M	$64.06M
Capital Expenditure	-$21.11M	-$19.96M	-$17.16M	-$15.63M
Free Cash Flow	$69.67M	$100.11M	$141.35M	$48.43M
Depreciation & Amortisation	$53.16M	$46.61M	$55.56M	$61.93M
Stock-Based Compensation	$23.11M	$25.59M	$23.31M	$29.54M
Investing Cash Flow	-$42.54M	-$19.89M	-$208.19M	-$74.32M
Financing Cash Flow	-$60.15M	-$97.85M	$56.94M	$276.33M
Share Repurchases	-$10.00M	$0.00	$0.00	-$39.28M
Net Change in Cash	-$11.92M	$2.33M	$7.27M	$266.06M

NOVT Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$233.37M	$241.05M	$247.84M	$258.35M	$257.71M
Cost of Revenue	$129.01M	$134.30M	$136.91M	$145.09M	$144.13M
Gross Profit	$104.35M	$106.75M	$110.92M	$113.26M	$113.58M
Research & Development	$23.24M	$25.29M	$24.09M	$22.87M	$23.25M
Selling, General & Admin	$45.60M	$47.10M	$51.38M	$51.58M	$54.41M
Operating Expenses	$74.39M	$79.26M	$82.40M	$82.57M	$83.43M
Operating Income	$29.97M	$27.48M	$28.52M	$30.69M	$30.14M
EBITDA	$43.53M	$43.06M	$44.24M	$47.77M	$44.30M
Pretax Income	$26.42M	$5.79M	$15.76M	$21.68M	$26.35M
Income Tax	$5.21M	$1.29M	$5.11M	$4.21M	$5.25M
Net Income	$21.21M	$4.50M	$10.65M	$17.47M	$21.10M
Diluted EPS	0.59	0.12	0.30	0.45	0.51
Diluted Shares	36.13M	36.08M	36.04M	38.68M	41.16M

NOVT Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$106.05M	$109.91M	$89.22M	$380.87M	$388.80M
Receivables	$170.03M	$169.36M	$180.32M	$194.26M	$182.69M
Inventory	$145.44M	$168.06M	$179.98M	$188.28M	$193.14M
Current Assets	$434.14M	$462.10M	$468.42M	$782.60M	$786.80M
Total Assets	$1.39B	$1.51B	$1.51B	$1.81B	$1.80B
Current Liabilities	$146.69M	$181.94M	$186.86M	$212.37M	$220.79M
Long-Term Debt	$385.28M	$454.04M	$445.66M	$212.54M	$201.00M
Total Debt	$442.53M	$513.41M	$504.48M	$301.91M	$290.49M
Total Liabilities	$615.70M	$709.62M	$704.34M	$492.82M	$488.03M
Retained Earnings	$288.76M	$293.25M	$303.91M	$321.38M	$342.48M
Shareholders' Equity	$769.75M	$801.45M	$801.48M	$1.31B	$1.31B
Working Capital	$287.45M	$280.16M	$281.56M	$570.23M	$566.01M
Net Debt	$284.09M	$349.33M	$362.12M	—	—

NOVT Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	$31.68M	$15.07M	$8.49M	$8.80M	$51.61M
Capital Expenditure	-$4.28M	-$3.39M	-$4.28M	-$3.67M	-$4.14M
Free Cash Flow	$27.40M	$11.68M	$4.21M	$5.13M	$47.47M
Depreciation & Amortisation	$13.56M	$15.58M	$15.71M	$17.08M	$14.16M
Stock-Based Compensation	$7.10M	$7.50M	$6.70M	$8.24M	$9.80M
Investing Cash Flow	$1.25M	-$66.56M	-$5.40M	-$3.61M	-$3.79M
Financing Cash Flow	-$42.73M	$54.83M	-$23.42M	$287.65M	-$40.12M
Share Repurchases	-$6.16M	$0.00	-$14.06M	-$19.07M	-$18.64M
Net Change in Cash	-$9.79M	$3.34M	-$20.33M	$292.84M	$7.69M

Market Snapshot

About

Novanta supplies precision photonics, vision, and motion control technology for medical equipment manufacturers and advanced industrial original equipment manufacturers.